Patient Demographics

You are looking at 1 - 1 of 1 items for :

Clear All
Verena Schwetz Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Search for other papers by Verena Schwetz in
Google Scholar
PubMed
Close
,
Felix Aberer Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Search for other papers by Felix Aberer in
Google Scholar
PubMed
Close
,
Claudia Stiegler Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Search for other papers by Claudia Stiegler in
Google Scholar
PubMed
Close
,
Thomas R Pieber Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Search for other papers by Thomas R Pieber in
Google Scholar
PubMed
Close
,
Barbara Obermayer-Pietsch Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Search for other papers by Barbara Obermayer-Pietsch in
Google Scholar
PubMed
Close
, and
Stefan Pilz Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Search for other papers by Stefan Pilz in
Google Scholar
PubMed
Close

Summary

Cushing's syndrome (CS) due to ectopic ACTH production accounts for about 10% of all types of CS and is frequently associated with metabolic alkalosis. Treatment of CS involves surgical resection and/or medical therapy to control hypercortisolism. We present the case of an 80-year-old woman affected by CS due to an unknown cause. The patient had severe metabolic alkalosis with refractory hypokalemia. To treat the underlying CS, fluconazole was initiated due to unavailability of ketoconazole. In spite of markedly decreasing cortisol levels, metabolic alkalosis persisted. Treatment of metabolic alkalosis with acetazolamide was thus initiated and pH levels successfully lowered. This case report shows that hypercortisolism can be effectively treated with fluconazole in cases where ketoconazole is unavailable or not tolerated and that persistent severe metabolic alkalosis caused by glucocorticoid excess can be safely and successfully treated with acetazolamide.

Learning points

  • Hypercortisolism can be effectively treated with fluconazole where ketoconazole is unavailable or not tolerated.

  • Glucocorticoid excess can cause severe metabolic alkalosis.

  • Persistent severe metabolic alkalosis can be safely and successfully treated with acetazolamide.

Open access